These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7260993)

  • 21. [Use of levamisol in rheumatic diseases].
    Bunchuk NV; Tsvetkova ES; Rachkov SM; Sigidin IaA
    Ter Arkh; 1977; 49(11):74-9. PubMed ID: 605405
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and immunological studies on the exacerbation of systemic lupus erythematosus (author's transl)].
    Komeji S; Kitamura M; Kashiwazaki S
    Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):448-57. PubMed ID: 7108329
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of treatment with encorton and cytostatics on cellular immunity in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1982; 20(3-4):137-42. PubMed ID: 7187069
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].
    Fuks A; Carballal G; Manni JA
    Medicina (B Aires); 1979; 39(3):289-97. PubMed ID: 514050
    [No Abstract]   [Full Text] [Related]  

  • 25. [The immune response of patients with visceral lupus erythematosus treated with corticosteroids (author's transl)].
    Horvat Z
    Lijec Vjesn; 1976; 98(10):523-7. PubMed ID: 1018580
    [No Abstract]   [Full Text] [Related]  

  • 26. [Levamisole-induced immunitary responses in patients operated from bronchogenic carcinoma (author's transl)].
    Wipf R; Stinghe R; Girard JP
    Poumon Coeur; 1979; 35(4):189-93. PubMed ID: 504048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphocyte adhesive properties in systemic lupus erythematosus].
    Isaeva LA; Levina SG; Geppe NA; Kuznetsov SL; Snesarevskaia IP
    Sov Med; 1980; (9):39-43. PubMed ID: 6158760
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of levamisole in lupus nephritis].
    Horiuchi A
    Nihon Jinzo Gakkai Shi; 1979 Apr; 21(4):280-3. PubMed ID: 480701
    [No Abstract]   [Full Text] [Related]  

  • 29. Levamisole in systemic lupus erythematosus.
    Smolen J; Scherak O; Menzel J; Kojer M; Kolarz G
    Arthritis Rheum; 1977; 20(8):1558-9. PubMed ID: 921830
    [No Abstract]   [Full Text] [Related]  

  • 30. [Interrelationships of cellular and humoral immunity indices in systemic lupus erythematosus].
    Matveĭkov GP; Dosin IuM; Kaliia ES; Koshelev VK; Nazarov IuM
    Ter Arkh; 1982; 54(12):44-8. PubMed ID: 6984235
    [No Abstract]   [Full Text] [Related]  

  • 31. [Visceral lupus erythematodes: increase of E-rosette cells using thymopoietin pentapeptide].
    Diezel W; Sönnichsen N; Koyka I; Forner K
    Dermatol Monatsschr; 1984; 170(3):166-8. PubMed ID: 6714497
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune rosette inhibiting activity of serum from patients with chronic lupus erythematosus treated with chloroquin].
    Nagy E; Szegedi G; Tamási P; Sonkoly I
    Dermatol Monatsschr; 1978 Jun; 164(6):408-10. PubMed ID: 308469
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of levamisole on immunological responsiveness in some systemic diseases of the connective tissue. (author's transl)].
    Popović M; Dujić A; Lilić D; Mićić R; Ivković L; Kolasinović N
    Lijec Vjesn; 1980 Jun; 102(6):317-20. PubMed ID: 7453479
    [No Abstract]   [Full Text] [Related]  

  • 34. Removal of a blocking factor from the sera of patients with systematic lupus erythematosus with Levamisole.
    Rosling AE; Rhodes EL; Watson B
    Clin Exp Dermatol; 1978 Mar; 3(1):39-42. PubMed ID: 348360
    [No Abstract]   [Full Text] [Related]  

  • 35. [Levamisole effects on collagen disease lymphocytes in vitro and in vivo (author's transl)].
    Hoshina H
    Nihon Naika Gakkai Zasshi; 1979 Jun; 68(6):620-30. PubMed ID: 479657
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
    Modai D; Peller S; Weissgarten J; Shaked U; Kaufman S
    Isr J Med Sci; 1981 Dec; 17(12):1115-8. PubMed ID: 7327910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ineffectiveness of levamisole in systemic lupus erythematosus: a controlled trial.
    Hadidi T; Decker JL; El-Nagdy L; Samy M
    Arthritis Rheum; 1981 Jan; 24(1):60-3. PubMed ID: 7008800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An immunohistochemical study of IgE in the skin of patients with systemic lupus erythematosus (author's transl)].
    Igarashi R
    Nihon Hifuka Gakkai Zasshi; 1975 Jun; 85(7):385-93. PubMed ID: 1081155
    [No Abstract]   [Full Text] [Related]  

  • 39. [Increased immune reactivity in Systemic lupus erythematosus. IV. enhanced activity of a granulocyte adherence inhibiting factor after immunization with brucella antigen (author's transl)].
    Günither W; Diezel W; Sönnichsen N
    Dermatol Monatsschr; 1978 Nov; 164(11):809-12. PubMed ID: 720712
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immune complexes in the lungs in systemic lupus erythematosus and rheumatoid arthritis (author's transl)].
    Music E; Remskar Z; Vizjak A
    Plucne Bolesti Tuberk; 1981; 33(2-3):161-5. PubMed ID: 7291370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.